Events

ACC-SFBA Patent Law Committee Meeting Sponsored by Sheppard Mullin LLP

Market Exclusivity – FDA Considerations in Patent Product Protection Strategies

Garden Court Hotel, Palo Alto
October 10, 2019

CLICK HERE TO REGISTER

Overview
Protecting a company’s substantial investment in drug and biologic discovery is key to a product’s commercial success. Market exclusivity has the potential to drive innovation for large and small molecules, and also orphan drugs and other niche drugs with a limited market. In this session, we will explore strategies for maximizing exclusivity from both a patent and FDA regulatory perspective. We also will discuss the opportunities and challenges of attaining market exclusivity from in-house attorneys at both large and small molecule companies.

Speaker

  • Lorna Tanner, Partner, Sheppard Mullin
  • Allison Fulton, Partner, Sheppard Mullin

Schedule
11:30 a.m. - 12:00 p.m. Registration 
12:00 p.m. - 1:00 p.m. Program
1:00 p.m. - 1:30 p.m. Networking

CLE
Credits: 1 Hour
State: CA
Category: General

Location
Garden Court Hotel
520 Cowper Street
Palo Alto, CA

Cost
Members: Free 
Non-members: $50